Lates News

Alamar Biosciences, a company specializing in the production of medical devices for detecting protein biomarkers to diagnose diseases, saw its shares rise by 29.41% on its first day of trading on the US stock market on Friday. The company's devices can detect and quantify over 100 protein biomarkers in a single sample with a minimum volume of only 10 microliters of biological fluid. According to the prospectus, the company's largest shareholder is Chinese venture capital firm Qiming Venture.